Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURE-POI
NCT07510139Phase 2Active, not recruiting
- Sponsor
- International Peace Maternity and Child Health Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of YT023 in premature ovarian insufficiency (POI), sponsored by International Peace Maternity and Child Health Hospital. Started Mar 2026; status: active, not recruiting.
02
Drugs
YT023
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07510139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07510139.